Nexeon MedSystems Inc. (NXNN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2017 | 2016 |
|---|---|---|
| Operating Cash Flow | -3.11 Million | 287.79 Thousand |
| Net Income | -2.17 Million | -802.46 Thousand |
| Depreciation & Amortization | 1.29 Million | 636.92 Thousand |
| Deferred income taxes | - | - |
| Stock-based compensation | - | - |
| Change in working capital | 485.49 Thousand | 25.79 Thousand |
| Other non-cash items | -189.63 Thousand | 1.75 Million |
| Investing Cash Flow | -1.1 Million | -1.08 Million |
| Investments in PPE | -61.66 Thousand | -32.56 Thousand |
| Acquisitions | -978.99 Thousand | -140 Thousand |
| Investment purchases | - | - |
| Sales/Maturities of investments | - | - |
| Other Investing Activities | -59.81 Thousand | -912.39 Thousand |
| Financing Cash Flow | 2.96 Million | 2.92 Million |
| Debt repayment | -1.64 Million | -64.99 Thousand |
| Dividends payments | - | - |
| Common Stock Repurchased | - | - |
| Common Stock Issuance | 1.32 Million | 2.86 Million |
| Other Financing Activities | - | - |
| Accounts receivables | -1 Million | -23.79 Thousand |
| Accounts payables | 1.17 Million | -27.62 Thousand |
| Inventory | -106 Thousand | - |
| Other working capital | 418.81 Thousand | 77.21 Thousand |
| Cash at beginning of period | 2.12 Million | -3978.00 |
| Cash at end of period | 883.96 Thousand | 2.12 Million |
| Capital Expenditure | -61.66 Thousand | -32.56 Thousand |
| Effect of forex changes on cash | - | - |
| Net cash flow / Change in cash | -1.24 Million | 2.12 Million |
| Free Cash Flow | -3.17 Million | 255.22 Thousand |
| Breakdown | 2017 FY | 2016 FY |
|---|---|---|
| Operating Cash Flow | - | - |
| Net Income | -2.17 Million | -802.46 Thousand |
| Depreciation & Amortization | 1.29 Million | 636.92 Thousand |
| Deferred income taxes | - | - |
| Stock-based compensation | - | - |
| Change in working capital | 485.49 Thousand | 25.79 Thousand |
| Other non-cash items | -189.63 Thousand | 1.75 Million |
| Investing Cash Flow | -1.1 Million | -1.08 Million |
| Investments in PPE | -61.66 Thousand | -32.56 Thousand |
| Acquisitions | -978.99 Thousand | -140 Thousand |
| Investment purchases | - | - |
| Sales/Maturities of investments | - | - |
| Other Investing Activities | -59.81 Thousand | -912.39 Thousand |
| Financing Cash Flow | 2.96 Million | 2.92 Million |
| Debt repayment | -1.64 Million | -64.99 Thousand |
| Dividends payments | - | - |
| Common Stock Repurchased | - | - |
| Common Stock Issuance | 1.32 Million | 2.86 Million |
| Other Financing Activities | - | - |
| Accounts receivables | -1 Million | -23.79 Thousand |
| Accounts payables | 1.17 Million | -27.62 Thousand |
| Inventory | -106 Thousand | - |
| Other working capital | 418.81 Thousand | 77.21 Thousand |
| Cash at beginning of period | 2.12 Million | -3978.00 |
| Cash at end of period | 883.96 Thousand | 2.12 Million |
| Capital Expenditure | -61.66 Thousand | -32.56 Thousand |
| Effect of forex changes on cash | - | - |
| Net cash flow / Change in cash | -1.24 Million | 2.12 Million |
| Free Cash Flow | -3.17 Million | 255.22 Thousand |
STRW
EAPI
FMANF
MOB
SALEM
005725